Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Filing Action Memo, April 20, 2009

Date: 20 April 2009
To: BLA Committee             
From: Lori A. Tull, RAC       
Subject: STN 125348/0 Filing Action        
I have reviewed the Clinical Study Report (Module 5) section(s) of Isolagen Technologies Incorporated’s BLA (STN Number 125348/0) and find the application acceptable for filing.
 (Signature of Committee Member)
(Supervisory Concurrence)

Page Last Updated: 07/19/2011
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.